000 01160 a2200373 4500
005 20250517183412.0
264 0 _c20191004
008 201910s 0 0 eng d
022 _a1615-6692
024 7 _a10.1007/s00059-017-4635-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMeng, Y
245 0 0 _aGenistein attenuates pathological cardiac hypertrophy in vivo and in vitro.
_h[electronic resource]
260 _bHerz
_cMay 2019
300 _a247-256 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aCardiomegaly
_xdrug therapy
650 0 4 _aGenistein
_xpharmacology
650 0 4 _aGlycogen Synthase Kinase 3 beta
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aMyocytes, Cardiac
_xdrug effects
650 0 4 _aProtein Kinase Inhibitors
_xpharmacology
650 0 4 _aRandom Allocation
700 1 _aZhang, Y
700 1 _aMa, Z
700 1 _aZhou, H
700 1 _aNi, J
700 1 _aLiao, H
700 1 _aTang, Q
773 0 _tHerz
_gvol. 44
_gno. 3
_gp. 247-256
856 4 0 _uhttps://doi.org/10.1007/s00059-017-4635-5
_zAvailable from publisher's website
999 _c27752711
_d27752711